BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Gastric Acidity Determination

Below is an extended Gastric Acidity Determination research listing. Click here to return to the Gastric Acidity Determination main in depth entry.

Recent Publications on Gastric Acidity Determination:

Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
OBJECTIVE: In patients with gastroesophageal reflux disease (GERD),...
Direct Link
30th August, 2008
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of
Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole. 30th August, 2008
Division of Gastroenterology, Tohoku University Graduate School of
Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.
PURPOSE: The aim of this study was to update the compositions of...
Direct Link
30th August, 2008
Institute of Pharmaceutical Technology, Johann Wolfgang Goethe University,
[Gastric and duodenal ulcer disease: morphofunctional, neuroendocrine and clinical parallels] 20th August, 2008
Transsphincteric pH profile at the gastroesophageal junction.
BACKGROUND & AIMS: Esophageal acid exposure conventionally is measured 5...
Direct Link
13th August, 2008
Department of Medicine, Temple University School of Medicine,
Role of acid and nonacid reflux in children with eosinophilic esophagitis compared with patients with gastroesophageal reflux and control patients.
OBJECTIVES: Because of the relationship between food and eosinophilic...
Direct Link
2nd August, 2008
Center for Motility and Functional Gastrointestinal Disorders, Children's
Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention.
Evidence suggests that distinct mechanisms underlie diabetic and...
Direct Link
2nd August, 2008
Division of Gastroenterology, Univ. of Michigan Health System, Ann Arbor,
Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.
BACKGROUND: The role of acid in functional dyspepsia is controversial and...
Direct Link
17th July, 2008
Department of Medical Gastroenterology, Glostrup University Hospital,
Proton pump inhibitors for dyspepsia.
Proton pump inhibitors are widely used in many upper gastrointestinal...
Direct Link
17th July, 2008
University of Wisconsin School of Medicine and Public Health, Madison,
When proton pump inhibitors fail.
Evidence suggests that distinct mechanisms underlie diabetic and...
Direct Link
17th July, 2008
[Multichannel intraluminal impedance associated with pH-metry in the study of gastroesophageal reflux disease] 17th July, 2008
Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
BACKGROUND & AIMS: Intravenous bolus plus infusion proton pump inhibitor...
Direct Link
8th July, 2008
Division of Gastrointestinal and Liver Diseases, Keck School of Medicine,
[Efficiency and safety of the intravenous application of esomeprazole (nexium - Astra Zeneca) in high risk patients subjected to mechanic ventilation] 24th June, 2008
Anaesteology, Reanimation and Intensive Care Clinic, University Hospital
[Morphologic and functional changes of upper parts of the digestive tract in patients with chronic diffuse diseases of the liver with portal hypertension according to endoscopy, pH-data, and bacteriological tests for helicobacteriosis] 10th June, 2008
Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
BACKGROUND: Persistent symptoms on acid suppressive therapy are due to...
Direct Link
31st May, 2008
Division of Gastroenterology and Hepatology, Medical University of South
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional